TMCI TREACE MEDICAL CONCEPTS, INC.

Nasdaq treace.com


$ 6.13 $ -0.08 (-1.29 %)    

Wednesday, 15-Oct-2025 15:59:55 EDT
QQQ $ 602.61 $ 4.22 (0.71 %)
DIA $ 463.04 $ 0.00 (0 %)
SPY $ 665.11 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.41 $ 6.60 (1.73 %)
$ 6.12
$ 6.20
$ 5.30 x 30
$ 6.93 x 8
$ 6.06 - $ 6.38
$ 4.54 - $ 10.79
206,295
na
386.62M
$ 1.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-27-2025 12-31-2024 10-K
4 11-05-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-08-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-06-2022 03-31-2022 10-Q
15 03-04-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-25-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-maintains-hold-on-treace-medical-concepts-lowers-price-target-to-7

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price ...

 truist-securities-maintains-hold-on-treace-medical-concepts-raises-price-target-to-8

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price ...

 ubs-maintains-neutral-on-treace-medical-concepts-lowers-price-target-to-65

UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:TMCI) with a Neutral and lowers the price target fro...

 stifel-maintains-hold-on-treace-medical-concepts-lowers-price-target-to-6

Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $9 to $6.

 treace-medical-concepts-affirms-fy2025-sales-guidance-of-224000m-230000m-vs-227030m-est

Treace Medical Concepts (NASDAQ:TMCI) affirms FY2025 sales outlook from $224.000 million-$230.000 million to $224.000 million-$...

 treace-medical-concepts-q2-eps-028-beats-029-estimate-sales-47387m-beat-47077m-estimate

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate ...

 treace-medical-concepts-announces-peer-reviewed-publication-of-the-4-year-interim-results-from-its-align3d-multicenter-prospective-study-demonstrating-clinical-and-radiographic-outcomes-of-the-lapiplasty-procedure-in-the-journal-of-foot--ankle-surgery

Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a...

Core News & Articles

Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a...

 ubs-maintains-neutral-on-treace-medical-concepts-lowers-price-target-to-86

UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:TMCI) with a Neutral and lowers the price target fro...

 treace-medical-concepts-affirms-fy2025-sales-guidance-of-22400m-23000m-vs-22753m-est

Treace Medical Concepts (NASDAQ:TMCI) affirms FY2025 sales outlook from $224.00 million-$230.00 million to $224.00 million-$230...

 treace-medical-concepts-q1-eps-025-beats-030-estimate-sales-5257m-beat-5207m-estimate

Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate ...

 truist-securities-maintains-hold-on-treace-medical-concepts-lowers-price-target-to-8

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price ...

 truist-securities-maintains-hold-on-treace-medical-concepts-lowers-price-target-to-95

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price ...

 truist-securities-maintains-hold-on-treace-medical-concepts-raises-price-target-to-10

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price ...

 treace-medical-concepts-sees-fy2025-sales-224000m-230000m-vs-22567m-est

Treace Medical Concepts (NASDAQ:TMCI) sees FY2025 sales of $224.000 million-$230.000 million vs $225.67 million analyst estimate.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION